Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xiangze Wang, Minghui Zhao, Chensheng Zhang, Haobo Chen, Xingyu Liu, Yang An, Lu Zhang & Xiangqian Guo. (2023) Establishment and Clinical Application of the Nomogram Related to Risk or Prognosis of Hepatocellular Carcinoma: A Review. Journal of Hepatocellular Carcinoma 10, pages 1389-1398.
Read now
Read now
Articles from other publishers (6)
Dandan Huang, Dafen Xu, Wenxin Chen, Ruimei Wu, Yujuan Wen, Ailin Liu, Liqing Lin, Xinhua Lin & Xuewen Wang. (2023) Fe-MnO2 nanosheets loading dihydroartemisinin for ferroptosis and immunotherapy. Biomedicine & Pharmacotherapy 161, pages 114431.
Crossref
Crossref
Tatyana I. Shabatina, Olga I. Vernaya, Nikolay L. Shimanovskiy & Mikhail Ya. Melnikov. (2023) Metal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents. Pharmaceutics 15:4, pages 1181.
Crossref
Crossref
Lyubov Agafonova, Elena Tikhonova, Maxim Sanzhakov, Lyubov Kostryukova & Victoria Shumyantseva. (2022) Electrochemical Studies of the Interaction of Phospholipid Nanoparticles with dsDNA. Processes 10:11, pages 2324.
Crossref
Crossref
Feinan Zhou, Jia Ma, Yongfu Zhu, Tianming Wang, Yue Yang, Yehan Sun, Youmou Chen, Hang Song, Xingxing Huo & Jianye Zhang. (2022) The role and potential mechanism of O-Glycosylation in gastrointestinal tumors. Pharmacological Research 184, pages 106420.
Crossref
Crossref
Adrian Bartos, Ioana Iancu, Lidia Ciobanu, Anca Onaciu, Cristian Moldovan, Alin Moldovan, Radu Cristian Moldovan, Adrian Bogdan Tigu, Gabriela Fabiola Stiufiuc, Valentin Toma, Cornel Iancu, Nadim Al Hajjar & Rares Ionut Stiufiuc. (2022) Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes—A Preliminary Study. Nanomaterials 12:16, pages 2833.
Crossref
Crossref
Chien-Hsiu Li, Yu-Chan Chang, Michael Hsiao & Ming-Hsien Chan. (2022) Ultrasound and Nanomedicine for Cancer-Targeted Drug Delivery: Screening, Cellular Mechanisms and Therapeutic Opportunities. Pharmaceutics 14:6, pages 1282.
Crossref
Crossref